Sun Pharma Ne Ki Organon Pe Badi Deal! $12 Billion Mein Khareeda, Global Reach Hogi 140+ Desho Mein

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Sun Pharma Ne Ki Organon Pe Badi Deal! $12 Billion Mein Khareeda, Global Reach Hogi 140+ Desho Mein
Overview

Sun Pharma ne Organon ko **$12 billion** mein khareedne ka final decision le liya hai, aur yeh deal poori cash mein hogi. Isse company ka global reach **140** se zyada desho mein phail jayega.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Sun Pharma Ne Ki Organon Pe Badi Deal!

Toh bhaiyon aur behnon, Sun Pharma ne ek bahut bada strategic move kiya hai. Inhone New Jersey wali company Organon ko 12 billion US dollars mein khareed liya hai, aur yeh pura paisa cash mein diya jayega. Is deal se Sun Pharma ka pura global presence aur product portfolio ekdum se change hone wala hai.

Portfolio Badhega, Reach Bhi Zyaada Hogi

Is acquisition se Sun Pharma ko kai fayde honge. Sabse pehle, inka product portfolio kaafi bada ho jayega aur doctors ke saath inke connections aur strong honge. Company ka ek alag se women's healthcare segment bhi add hoga, aur jo pehle se biosimilars banate hain, woh aur strong ho jayenge. Sabse mazedaar baat yeh hai ki company ka business ab 140 se bhi zyada desho mein pahunch jayega.

Global Position Hogi Aur Mazboot

Yeh expansion khaas kar America, Europe, China, Canada aur Brazil jaise important markets par focus karega. Motilal Oswal ke analysts ne kaha hai ki yeh deal Sun Pharma ki global position ko aur mazboot karegi aur alag-alag products mein diversification layegi. Unhone stock par 'BUY' rating maintain rakhi hai aur target price ko ₹2,025 set kiya hai, jo ki lagbhag 32 times ke 12-month forward earnings par based hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.